These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 13490)
61. Sympathectomy for hypertension. De Takats G Am J Surg; 1974 May; 127(5):521-4. PubMed ID: 4150774 [No Abstract] [Full Text] [Related]
62. Proceedings: Mode of action of beta-adrenergic receptor blocking drugs in hypertension. Oliver NW Scott Med J; 1974 Jan; 19(1):43-4. PubMed ID: 4150625 [No Abstract] [Full Text] [Related]
63. [Present status of research on hypertension-inducing substances]. Matsunaga M Nihon Rinsho; 1973 Nov; 31(11):3163-9. PubMed ID: 4360307 [No Abstract] [Full Text] [Related]
64. Renin levels and cardiovascular morbidity: a prospective study of the effect of beta-adrenergic blocking drugs. Hauger-Klevene JH Curr Med Res Opin; 1981; 7(7):443-51. PubMed ID: 6114813 [TBL] [Abstract][Full Text] [Related]
65. Renal effects of beta blockade in essential hypertension. de Leeuw PW; Birkenhäger WH Eur Heart J; 1983 Jul; 4 Suppl D():13-7. PubMed ID: 6137372 [TBL] [Abstract][Full Text] [Related]
66. Beta-blockers after myocardial infarction. Rose G Aust N Z J Med; 1984 Aug; 14(4):431-4. PubMed ID: 6151389 [TBL] [Abstract][Full Text] [Related]
67. beta-Adrenoceptor blockade and the incidence of myocardial infarction during treatment of severe hypertension. Stewart IM Br J Clin Pharmacol; 1982 Jan; 13(1):91-3. PubMed ID: 6121575 [No Abstract] [Full Text] [Related]
68. Letter: Beta-adrenergic blocking agents in renal failure. Kincaid-Smith P; Hua AS Br Med J; 1974 Aug; 3(5929):520. PubMed ID: 4153388 [No Abstract] [Full Text] [Related]
69. Symposium on hypertension: Part II. Renin profiling and drug therapy, childhood hypertension, prorenin, the physiology of renin secretion. Introduction. Laragh JH Am J Cardiol; 1976 Mar; 37(4):635-6. PubMed ID: 3962 [No Abstract] [Full Text] [Related]
70. First line treatment in hypertension. Swales JD BMJ; 1990 Nov; 301(6762):1172-3. PubMed ID: 1979755 [No Abstract] [Full Text] [Related]
72. The effects of catecholamines on the cardiovascular system. Offermeier J S Afr Med J; 1978 Jun; 53(24):966-9. PubMed ID: 29344 [No Abstract] [Full Text] [Related]
73. Impact of the ALLHAT study results on managed care. Anderson RJ J Manag Care Pharm; 2003; 9(1):84-6. PubMed ID: 14613367 [No Abstract] [Full Text] [Related]
74. Editorial: New treatment for ulcerative colitis? Br Med J; 1976 Jan; 1(6000):2. PubMed ID: 2361 [No Abstract] [Full Text] [Related]
75. The renin-angiotensin system and its relation to hypertension. Helmer OM Prog Cardiovasc Dis; 1965 Sep; 8(2):117-28. PubMed ID: 4283886 [No Abstract] [Full Text] [Related]
76. Significance of angiotensinase on renin-angiotensin system. Yamamura Y Jpn Circ J; 1966 Feb; 30(2):186-8. PubMed ID: 4285927 [No Abstract] [Full Text] [Related]
77. Oxprenolol in senile tremor. Thompson MK Scott Med J; 1975 Nov; 20(6):291-2. PubMed ID: 4891 [No Abstract] [Full Text] [Related]
78. Does angiotensin-II protect against strokes? Brown MJ; Brown J Lancet; 1986 Aug; 2(8504):427-9. PubMed ID: 2874416 [TBL] [Abstract][Full Text] [Related]
79. Nomenclature of the renin-angiotensin system. Report of the nomenclature Committee of the International Society of Hypertension. Hypertension; 1979; 1(6):654-6. PubMed ID: 396250 [No Abstract] [Full Text] [Related]
80. Diseases of the urinary system. High blood pressure and renal disease. MacGregor GA Br Med J; 1977 Sep; 2(6087):624-6. PubMed ID: 20193 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]